Regression of new-onset diabetes mellitus after conversion from tacrolimus to cyclosporine in liver transplant patients: Results of a pilot study

Clinics and Research in Hepatology and Gastroenterology

Volumn 35, Issue 6-7, 2011, Pages 482-488

  Lorho, R ^a   Hardwigsen, J ^b   Dumortier, J ^c   Pageaux, G P ^d   Durand, F ^e   Bizollon, T ^f   Blanc, A S ^g   Di Giambattista, F ^g   Duvoux, C ^h  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b HÔPITAL DE LA CONCEPTION   (France)

^c EDOUARD HERRIOT HOSPITAL   (France)

^d HÔPITAL SAINT ELOI   (France)

^e BEAUJON HOSPITAL   (France)

^f HÔTEL DIEU   (France)

^g NOVARTIS PHARMA K K   (Japan)

^h HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ASPARTATE AMINOTRANSFERASE; BIGUANIDE; BILIRUBIN; CHOLESTEROL; CORTICOSTEROID; CREATININE; CYCLOSPORIN A; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; RAPAMYCIN; REPAGLINIDE; SULFONYLUREA; TACROLIMUS; TRIACYLGLYCEROL;

ABDOMINAL PAIN; ACUTE GRAFT REJECTION; ADULT; AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CAUSE OF DEATH; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CORTICOSTEROID THERAPY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETES MELLITUS; DIARRHEA; DIASTOLIC BLOOD PRESSURE; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GINGIVA HYPERPLASIA; GLUCOSE BLOOD LEVEL; GRAFT RECIPIENT; HEMOGLOBIN BLOOD LEVEL; HEPATITIS C; HUMAN; LIVER TRANSPLANTATION; MALE; MULTICENTER STUDY; NEW ONSET DIABETES MELLITUS; NUTRITIONAL SUPPORT; OPEN STUDY; OROPHARYNX CANCER; PILOT STUDY; PROSPECTIVE STUDY; REMISSION; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

EID: 80052317853     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2011.03.008     Document Type: Article

References (34)

1. Kaufman DB, Shapiro R, Lucey MR, Cherikh WS, Bustami TR, Dyke DB. Immunosuppression: practice and trends. Am J Transplant 2004;4(Suppl. 9):38-53.
2. O'Grady JG, Burroughs A, Hardy P, Elbourne D, Truesdale A, the UK Republic of Ireland Liver Transplant Study Group. Tacrolimus versus microemulsified ciclosporin in liver transplantation: the TMC randomised controlled trial. Lancet 2002;360:1119-25.
3. 0 monitoring in de novo liver transplantation. Transplantation 2004;77:1632-8.
4. Heisel O, Heisel R, Balshaw R, Keown P. New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis. Am J Transplant 2004;4:583-95.
5. Saliba F, Lakehal M, Pageaux GP, et al. Risk factors for newonset diabetes mellitus following liver transplantation and impact of hepatitis C infection: an observational multicentre study. Liver Transpl 2007;13:136-44.
6. Davidson J, Wilkinson A, Dantal J, et al. New-onset diabetes after transplantation: 2003 international consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. Transplantation 2003;75(10 suppl.):SS3-24.
7. John PR, Thuluvath PJ. Outcome of patients with new-onset diabetes mellitus after liver transplantation compared with those without diabetes mellitus. Liver Transpl 2002;8:708-13.
8. Muñoz SJ, Elgenaidi H. Cardiovascular risk factors after liver transplantation. Liver Transpl 2005;11(11 Suppl. 2):S52-6.
9. Moon JI, Barbeito R, Faradji RN, Gaynor JJ, Tzakis AG. Negative impact of new-onset diabetes mellitus on patient and graft survival after liver transplantation: long-term follow-up. Transplantation 2006;82:1625-8.
10. Baid S, Cosimi AB, Farrell ML, et al. Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality. Transplantation 2001;72:1066-72.
11. Benhamou PY, Penfornis A. Natural history, prognosis and management of transplantation-induced diabetes mellitus. Diabetes Metab 2002;28:166-75.
12. Bigham DL, Pennington JJ, Carpentier A, et al. Hepatitis C-related cirrhosis: a predictor of diabetes after liver transplantation. Hepatology 2000;32:87-90.
13. Knobler H, Schihmanter R, Zifroni A, Fenakel G, Schattner A. Increased risk of type 2 diabetes in nonchirrotic patients with chronic hepatitis C infection. Mayo Clin Proc 2000;75:355-9.
14. Soule JL, Olyaei AJ, Boslaugh TA, et al. Hepatitis C infection increases the risk of new-onset diabetes after transplantation in liver allograft recipients. Am J Surg 2005;189:552-7.
15. Khalili M, Lim JW, Bass N, Ascher NL, Roberts JP, Terrault NA. New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection. Liver Transpl 2004;10:349-55.
16. Parolin MB, Zaina FE, Araújo MV, Kupka E, Coelho JC. Prevalence of new-onset diabetes mellitus in Brazilian liver transplant recipients: association with HCV infection. Transplant Proc 2004;36:2776-7.
17. Ericzon B, Groth C, Bismuth H, et al. Glucose metabolism in liver transplant recipients treated with FK506 or cyclosporin in the European multicentre study. Transplant Int 1994;7(Suppl.):S11-4.
18. Lohmann T, List C, Lamesch P, et al. Diabetes mellitus and islet cell specific autoimmunity as adverse effects of immunosuppressive therapy by FK506/tacrolimus. Exp Clin Endocrinol Diabetes 2000;108:347-52.
19. AlDosary AA, Ramji AS, Elliott TG, et al. Postliver transplant diabetes mellitus: an association with hepatitis C. Liver Transplant 2002;8:356-61.
20. Vincenti F, Friman S, Scheuermann E, et al. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant 2007;7:1506-14.
21. Ekberg H, Tedesco-Silva H, Demirbas A, et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 2007;357:2562-75.
22. Silva HT, Yang HC, Abouljoud M, et al. One-year results with extended-release tacrolimus/MMF, tacrolimus/MMF and cyclosporine/MMF in de novo kidney transplant recipients. Am J Transplant 2007;6:595-609.
23. Redmon JB, Olson LK, Armstrong MB, Greene MJ, Robertson MP. Effects of tacrolimus (FK506) on human insulin gene expression, insulin mRNA levels, and insulin secretion in HIT-T15 cells. J Clin Invest 1996;98:2786-93.
24. Wyzgal J, Pa{ogonek}ceck L, Sańko-Resmer J, et al. Insulin resistance in kidney allograft recipients treated with calcineurin inhibitors. Ann Transplant 2007;12:26-9.
25. David-Neto E, Lemos FC, Fadel LM, et al. The dynamics of glucose metabolism under calcineurin inhibitors in the first year after renal transplantation in nonobese patients. Transplantation 2007;84:50-5.
26. Dumortier J, Bernard S, Bouffard Y, Boillot O. Conversion from tacrolimus to cyclosporine in liver transplanted patients with diabetes mellitus. Liver Transpl 2006;12: 659-64.
27. Abouljoud MS, Kumar MS, Brayman KL, Emre S, Bynon JS, for the OLN-452 Study Group. Neoral rescue therapy in transplant patients with intolerance to tacrolimus. Clin Transplant 2002;16:168-72.
28. Bouchta NB, Ghisdal L, Abramowicz D, et al. Conversion from tacrolimus to cyclosporin is associated with a significant improvement of glucose metabolism in patients with new-onset diabetes mellitus after renal transplantation. Transplant Proc 2005;37:1857-60.
29. Cosio FG, Pesavento TE, Osei K, Henry ML, Ferguson RM. Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years. Kidney Int 2001;59:732-7.
30. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ. Diabetes mellitus after transplantation in the United States. Am J Transplant 2003;3:178-85.
31. Lucey MR, Abdelmalek MF, Gagliardi R, et al. A comparison of tacrolimus and cyclosporine in liver transplantation: effects on renal function and cardiovascular risk status. Am J Transplant 2005;5:1111-9.
32. 2 monitoring) and tacrolimus. Liver Transpl 2006;12:1464-72.
33. 2). Transplantation 2002;73:953-9.
34. 2 monitoring of cyclosporine in de novo liver transplant recipients: the clinician's perspective. Liver Transpl 2004;10:577-83.